Up $3 Van nice pick. These guys are the breast implants guys? I can certainly ' support ' that! It's a growing business. Firm results! We're making ESTA our Cyber-Monday Gummy Pick. $ESTA-------> $66.41 I don't remember you talking this one out... Is it still a BUY? What is the PT? Nov 9) Establishment Labs raises FY21 revenue view to $124M-$128M from $122M-$126M 11/09 ESTA Consensus $124.86M. The company said, "In addition, our JOY and MIA programs are progressing. These advances are not only opening up significant new markets, they are also allowing us to have a more direct relationship with women on their journey with Motiva. Our regulatory and commercial timelines to begin selling Motiva implants in the U.S. and Chinese markets are also progressing as planned. We remain on a clear path to becoming the leader in breast aesthetics and reconstruction, and to expand these markets as we offer safe, differentiated, and accessible solutions to women." Chinese breast implant market?
Undoubtedly better Van. it's weird this tech was 6 years ago. Still rolling out...? Lots of old Youtube videos... Is it possible they do not make a profit? EPS - $1.37 In fact, the recent purchase by Edward Schutter was the biggest purchase of Establishment Labs Holdings shares made by an insider individual in the last twelve months, according to our records. That means that even when the share price was higher than US$66.76 (the recent price), an insider wanted to purchase shares. Vol Analyssis) Woa Volume 29,869<------- Warning low Vol Avg. Volume 98,369 I dunno Van I think we can do better. Must have real earnings I think... But it is small cap right?
New stock: $PATH It's selling off, anything in the low $45's buy it. High growth. Software robots. Software that writes software. (It's climbing as I write)
UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows. The company also offers UiPath Robots, which emulates human behavior to execute the processes built in UiPath Studio; and UiPath Orchestrator that tracks and logs robot activity, along with what people do in tandem to maintain strict compliance and governance through dashboards and visualization tools. In addition, it provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. UiPath Inc. was founded in 2005 and is headquartered in New York, New York. This one should go on a shopping list for the next big tech correction actually. The lock-up expired in early October and it didn't move that much. I think its a solid, albeit pricey stock. It may not go much lower, we'll have to see what happens tomorrow. $46 now. I'd wait for a correction though. With that said, I could also see it hitting $50 tomorrow after that report. They sand-bagged the guidance that's for sure. This one is growing fast. Next Q they reaffirmed 282M, this Q they generated 220M with analysts estimating 208M. This might be one of my top picks for 2022, but we'll wait for the end of December and decide then. PATH------> $46 as I type.